Lanreotide
Lanreotide
Lanreotide (/lænˈriːoʊtaɪd/) is a synthetic analogue of somatostatin, a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G-protein-coupled somatostatin receptors.
Etymology
The term "Lanreotide" is derived from the combination of Lanthanum and peptide, indicating its synthetic peptide nature.
Usage
Lanreotide is used primarily in the treatment of acromegaly, a hormonal disorder that results when the pituitary gland at the base of the brain produces too much growth hormone. It is also used for symptoms associated with neuroendocrine tumors. Most of these tumors are found in the gastrointestinal system, but they can also be found in the pancreas, lung, and the rest of the body.
Mechanism of Action
Lanreotide works by decreasing the amount of growth hormone that the body produces. It does this by binding to somatostatin receptors, which sends a signal to the pituitary gland to reduce the production of growth hormones.
Related Terms
- Somatostatin
- Acromegaly
- Neuroendocrine tumors
- G-protein-coupled somatostatin receptors
- Pituitary gland
See Also
External links
- Medical encyclopedia article on Lanreotide
- Wikipedia's article - Lanreotide
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski